Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?

University Of Toronto Study Offers Hope To Sufferers Of Chronic Fatigue Syndrome

Friday 7 April 2017

 

From the University of Toronto:

 

Wilfred de Vega and Patrick Gowan
New research by U of T Scarborough researchers
Wilfred de Vega, a PhD student, and Associate Professor
Patrick McGowan may offer hope to patients
suffering from chronic fatigue syndrome
(Photo by Ken Jones)
 

U of T study offers hope to sufferers of chronic fatigue syndrome

By Don Campbell
April 4, 2017

A new U of T study may lead to help for sufferers of chronic fatigue syndrome (CFS) who face debilitating fatigue that can't be cured by rest.

The study, which looks at epigenetic changes in people with CFS, is the first to identify differences in sensitivity to a hormone found in the body. Epigenetic changes can be caused by environmental triggers like toxins, stress, nutrition or infections, and while the change doesn’t alter the gene itself, it influences how and when a gene is turned off.

By identifying these changes, researchers can then start to develop ways of testing drugs already in use or develop new therapies.

“Hopefully these results will offer CFS patients some hope,” says lead author Wilfred de Vega, a PhD student in Associate Professor Patrick McGowan’s biological sciences lab at U of T Scarborough.

 

Full article…

 


 

blog comments powered by Disqus
Previous Previous Page